ExAdEx-Innov develops a patented 3D ex vivo platform utilizing real human adipose tissue to generate reliable data for pharmaceutical and dermo-cosmetic research. This technology addresses the limitations of traditional testing methods by providing human-relevant insights that enhance drug development and product efficacy while reducing reliance on animal models.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional pharmaceutical and dermo-cosmetic research relies heavily on animal models and 2D cell cultures, which often fail to accurately predict human responses, leading to costly failures in later-stage clinical trials and product development. The lack of human-relevant data in early research stages slows progress, increases costs, and limits innovation in treating conditions like obesity, metabolic diseases, and cosmetic concerns.
Solution
ExAdEx-Innov offers a patented 3D ex vivo platform utilizing real human adipose tissue to generate human-relevant data for pharmaceutical, dermo-cosmetic, and aesthetic medicine research. The platform overcomes the limitations of traditional testing methods by providing a 3D microenvironment that mimics pathological conditions and allows for first-in-human data generation. By using donor-derived human adipose tissue biopsies, the ExAdEx technology stimulates a subpopulation of actively proliferating adipose stem cells to expand within native endogenous 3D mini-tissue units, retaining full matrix structure, vascular, and lymphatic networks without exogenous material. This approach bridges the gap between preclinical testing and clinical outcomes, reducing the need for animal models and improving translational success.
Target Audience
The primary customers are pharmaceutical companies researching treatments for obesity and metabolic diseases, as well as dermo-cosmetic companies seeking innovative and scientifically backed product testing and claim validation.
Features
- Patented ExAdEx technology for 3D ex vivo culture of human adipose tissue.
- Donor-derived human adipose tissue biopsies to create 3D mini-tissue units.
- Native extracellular matrix that acts as a 3D bioactive support.
- Preservation of vascular and lymphatic networks within the tissue models.
- Mimicking of pathological conditions relevant to obesity and chronic metabolic diseases.
- Support for dermo-cosmetic, nutraceutical, and aesthetic medicine research.
- Advanced data analysis to support claims related to dark circles and puffiness under the eyes.
- 3D and 4D imaging techniques for quantitative evaluation of vascular and lymphatic networks.